44 participants
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2021-11-01
- Completion:
- 2027-12-31
Conditions
- Breast Cancer
Interventions
- DRUG
No Results Yet